Search Within

Population Sciences Research Program

  1. "Journal for ImmunoTherapy of Cancer"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
  3. Correspondence (1)
  4. Editorial (1)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (20)
  3. GSK Faculty (13)
  4. Biostatistics Service (12)
  5. Epidemiology and Biostatistics (12)
  6. Melanoma and Immunotherapeutics Service (12)

More Groups

People
  1. Jedd Wolchok (10)
  2. Katherine Panageas (10)
  3. Michael Postow (5)
  4. Cailian Liu (3)
  5. Jianda Yuan (3)
  6. Margaret Callahan (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (3)
  6. 2018 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (21)
Publishers
  1. Biomed Central Ltd (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to Yu and Fuhler et al
    Correspondence

    Magahis, P. T.; Maron, S. B.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor
    Meeting Abstract

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Callahan, M.; Panageas, K.; Shen, R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Ensuring equity in the era of HLA-restricted cancer therapeutics
    Editorial

    Smithy, J. W.; Blouin, A.; Diamond, L. C.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients
    Meeting Abstract

    Knorr, D.; Ravetch, J.; D'Andrea, G.; Vahdat, L.; Klebanoff, C.; Robson, M.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save